Cotecna Life Sciences India Private Limited, formerly Geo-Chem Pharma, is proud to announce the inauguration of its new, state-of-the-art laboratory in Mumbai. This development represents a significant step in supporting the rapid growth of India’s pharmaceutical industry and demonstrates Cotecna’s dedication to fostering innovation, quality,
Mumbai, December 17, 2024 – Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine
Biocon Biologics, a leading subsidiary of Biocon Ltd., has achieved a significant milestone with the U.S. Food and Drug Administration (USFDA) approval for its biosimilar version of Janssen's Stelara (Ustekinumab). This approval, granted under the rigorous 351(k) regulatory pathway, is poised to address the growing
Revolutionary technology will further boost OneSource’s scientific services offerings OneSource Specialty Pharma Limited, associate company of Strides and India’s first specialty pharma pure-play CDMO (Contract Development and Manufacturing Organization) has entered into a strategic licensing agreement with Bhami’s Research Laboratory (BRL). This partnership will provide OneSource
Gland Pharma Limited (Gland or Company), a generic injectable-focused pharmaceutical company, has received tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024%. The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Vyzulta® Ophthalmic Solution,
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation Approval bolsters Strides’ portfolio for the US by adding another differentiated and niche product with limited competition Strides Pharma Science Limited (Strides) today announced that its step-down wholly
Sevelamer Carbonate Tablets approval consolidates the Company's position in the Sevelamer segment by complementing the existing approval of Sevelamer for Oral Suspension Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval
Early stage investor Karna D Shinde has invested in neuro42 over multiple rounds in the last few years In a recent announcement, neuro42, a medical technology company pioneering portable MRI, robot and AI technologies has secured undisclosed investments from investor, Karna D Shinde. This is Karna’s
Aparna Pharmaceuticals Private Limited, a leader in manufacturing Active Pharmaceutical Ingredients (APIs) and Advanced Drug Intermediates, is pleased to announce that its manufacturing facility, Aparna Organics Limited, located in Pydibhimavaram, Srikakulalam, Andhra Pradesh, India has received VAI classification from the United States Food and Drug
In its steadfast commitment to enhancing quality healthcare access, Mankind Pharma, a leading pharmaceutical company is proud to unveil a significant stride with the introduction of 120 DMF (Drug Master File) Quality Medicines in the Indian market. Committed to delivering exceptional healthcare solutions at affordable
